Tag: Access Vascular
New retrospective data demonstrate midline catheters composed of advanced biomaterials may...
Access Vascular has shared initial findings from a retrospective review of patient records that demonstrate an increase in dwell times compared to other commercially...
Access Vascular secures US$20 million in Series B financing
Access Vascular recently announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a US$15...
HydroMID midline catheter from Access Vascular receives FDA clearance
Access Vascular has announced US Food and Drug Administration (FDA) clearance of its HydroMID midline catheter.
A press release from the company states that...
Mentice launches VIST G7 endovascular simulation platform
Mentice AB has announced the global introduction of its seventh-generation Vascular Interventional System Trainer (VIST) simulation platform.
According to the company, the VIST G7 includes...
Access Vascular receives FDA clearance for its HydroPICC catheter
Access Vascular has announced that the company received 510(k) clearance from the US Food and Drug Administration (FDA) for its lead product, the HydroPICC,...
Access Vascular secures US$3.7m in financing
Access Vascular has announced US$3.7m in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical start-ups, physicians, investors and industry partners....
